Evidence Based Cosmeceuticals for a Fitzpatrick Skin Type II Patient
Received Date: Jul 12, 2017 / Accepted Date: Sep 08, 2017 / Published Date: Sep 29, 2017
Abstract
Cosmeceuticals are defined as agents claiming to have medicinal properties, example anti-ageing etc. These are supported with weak clinical data. A Fitzpatrick skin type II usually burns and tans minimally. At the age of 55, sundamaged females would have lost a fair bit of collagen and elastin from their dermis layer. Pigmentation with freckles and solar lentigosis are common, especially amidst sun exposure and lack of a good skincare regimen. Skin tends to be drier and more prone to erythema, due to weakening of the stratum corneum skin barrier and inflammation. Therefore, it is vital to commence a long term skin care maintenance regimen to improve skin appearance and reduce further photo-damage. Toxins target the muscle layer and help reduce dynamic rhytides, while cosmeceuticals would improve the static rhytides. Fillers help replace lost volume in the subcutaneous layer, most commonly in the deep fat compartments of the face. This leaves the epidermis and dermis layer, which can be improved with cosmeceuticals.
Keywords: Rhytides; Neurotransmitter; Melanosome; Corneum; Rosacea
Citation: Chang D (2017) Evidence Based Cosmeceuticals for a Fitzpatrick Skin Type II Patient. Cosmetol & Oro Facial Surg 3: 121.
Copyright: © 2017 Chang D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Usage
- Total views: 4062
- [From(publication date): 0-2017 - Dec 13, 2024]
- Breakdown by view type
- HTML page views: 3386
- PDF downloads: 676